DHG Pharma Maintains 14-Year Streak in Vietnam’s Top 50 Most Efficient Business Companies

A Shining Star in Business Efficiency Rankings

DHG Pharma has been honored in the Top 50 Most Efficient Companies in Vietnam 2025 (TOP50) for the 14th consecutive year, as evaluated by Investment Bridge Magazine and Thien Viet Securities. This marks the 14th year in a row the company has made its mark on this prestigious list, solidifying its position as the leading domestic pharmaceutical company in the country.

“Over the past 14 years, we have witnessed the proud development of DHG Pharma, significantly contributing to the continuous growth of Vietnam’s economy,” emphasized Mrs. Le Thi Bich Ngoc, Editor-in-Chief of Investment Bridge Magazine.

Mrs. Bich Ngoc added that the ranking was conducted with the consultation of leading economic experts from Harvard Business School (USA), aiming to identify and honor the most efficient companies on the Vietnamese stock market.

DHG Pharma was highly rated for its business performance over the past three years, across all three growth indicators: revenue, return on equity, and earnings per share. These metrics objectively reflect the company’s management capabilities, making it a source of national pride.

At the 2025 Customer Conference themed “Resilient Transformation – Steadfast Growth,” DHG Pharma aims to bring prosperity to its customers and society.

Previously, on August 21, DHG Pharma was also honored by Forbes in the “Top 50 Best Listed Companies in Vietnam” for the 13th consecutive year. Not only recognized for its financial health, DHG Pharma also maintains its leading position in the industry, being one of the three pharmaceutical companies in the Forbes Top 50 2025.

Reflecting on the series of prestigious awards, Mr. Toshiyuki Ishii, CEO of DHG Pharma, shared: “Alongside our growth strategy, DHG Pharma’s achievements today are also thanks to the immense trust of our customers. Over the past 51 years, we are proud to have received the companionship of the largest pharmacy system in the country, steadfastly standing by us through market fluctuations.”

Mr. Toshiyuki Ishii further emphasized that customers are the “extended arm” helping the company reach a leading market share in the over-the-counter drug segment. As a result, DHG Pharma has maintained its top revenue position in the retail pharmaceutical market (excluding vaccines) for five consecutive years from 2020 to 2024, according to IQVIA.

DHG Pharma was highly rated for its business performance over the past three years, across all three growth indicators: revenue, return on equity, and earnings per share.

DHG Pharma currently owns two Betalactam and Non-Betalactam factories meeting international standards of JAPAN-GMP and EU-GMP, reinforcing its vision of producing “international-quality domestic drugs.” In addition to over 150 products manufactured at these facilities, the company is also expanding and transferring many products from the Taisho Group (Japan) to serve the domestic market.

Betalactam and Non-Betalactam factories meeting international standards of JAPAN-GMP and EU-GMP.

“We expect products manufactured on production lines meeting Japanese and European standards to propel DHG Pharma closer to and more connected with our customers. In every step, DHG remains committed to quality, reputation, and dedication to delivering sustainable value to partners and society,” said CEO Toshiyuki Ishii.

Dual standards of JAPAN-GMP and EU-GMP affirm DHG Pharma’s top-tier quality.

Recognition in these prestigious awards has affirmed DHG Pharma’s exceptional management capabilities and commitment to sustainable development. Over the past half-century, DHG Pharma has consistently aimed not only to grow its business but also to actively contribute to the community through social welfare programs, environmental protection, education, and healthcare.

Alongside accelerating its digital transformation strategy and enhancing customer experience with various policies and convenient services, DHG Pharma focuses on investing in human resource development, building a professional team to meet the increasingly high demands of the market and international integration.

In its 51-year journey of upholding trust, DHG Pharma remains committed to providing high-quality products and services, fulfilling the aspiration for a healthier and more beautiful life.